Clinical evaluation and management of benign soft tissue tumors of the extremities

Cancer Treat Res. 2014:162:171-202. doi: 10.1007/978-3-319-07323-1_9.

Abstract

Benign lesions comprise a majority of soft tissue tumors. It has been estimated that their incidence outnumbers that of malignant tumors by a factor of at least 100 [1]. While history and physical examination can start the diagnostic process, imaging including the use of magnetic resonance imaging can be more helpful. Biopsy of these tumors is sometimes necessary and can be performed in a number of ways, often in conjunction with definitive treatment. Specific diagnostic and treatment strategies for a number of the more commonly encountered benign soft tissue tumors including lipomas, pigmented villonodular synovitis and hemangiomas are reviewed. An algorithm for the management of benign soft tissue tumors is discussed.

Publication types

  • Review

MeSH terms

  • Algorithms
  • Biopsy
  • Bone Neoplasms / diagnosis*
  • Bone Neoplasms / therapy
  • Fasciitis / diagnosis
  • Fasciitis / therapy
  • Fibroma / diagnosis
  • Fibroma / therapy
  • Giant Cell Tumors / diagnosis
  • Giant Cell Tumors / therapy
  • Glomus Tumor / diagnosis
  • Glomus Tumor / therapy
  • Hemangioma / diagnosis
  • Hemangioma / therapy
  • Humans
  • Incidence
  • Lipoma / diagnosis
  • Lipoma / therapy
  • Magnetic Resonance Imaging
  • Muscle Neoplasms / diagnosis*
  • Muscle Neoplasms / therapy
  • Myxoma / diagnosis
  • Myxoma / therapy
  • Nerve Sheath Neoplasms / diagnosis
  • Nerve Sheath Neoplasms / therapy
  • Positron-Emission Tomography
  • Soft Tissue Neoplasms / diagnosis*
  • Soft Tissue Neoplasms / therapy
  • Synovitis / diagnosis
  • Synovitis / therapy
  • Tomography, X-Ray Computed
  • Treatment Outcome